PERIOPERATIVE DEXMEDETOMIDINE INFUSION FOR CARDIAC AND RENAL PROTECTION IN CARDIAC SURGERIES

Authors

  • Dr. Mansha Madan
  • Dr. Meenakshi Kumar
  • Dr. Sushil Guria
  • Dr. Aadhar Khutell
  • Dr. Simarjot Singh Sodhi

DOI:

https://doi.org/10.53555/5253z295

Keywords:

Dexmedetomidine, cardiac and renal protection, cardiac surgery.

Abstract

INTRODUCTION: Cardiac surgeries performed under cardiopulmonary bypass (CPB) are not devoid of adverse effects related to cardiac and renal injuries. Dexmedetomidine, an alpha-2-agonist, is shown to have protective role.

MATERIAL AND METHODS

AIM: To study the role of perioperative dexmedetomidine infusion on cardiac and renal protection during valvular heart surgeries.

This prospective, interventional and randomised study included 50 adult patients scheduled for elective valvular heart surgeries under CPB. The patients were  randomised into 2 groups (1 and 2). Group 1 received dexmedetomidine at initiation of CPB at 0.5 mcg/kg bolus over 10 minutes followed by infusion at 0.25 mcg/kg/hr till extubation. Group 2 received standard cardiac anaesthesia care protocol. Cardiac enzymes (CPK-MB, LDH),  renal parameters (Blood urea, serum creatinine, creatinine clearance, total urine output) , serum electrolytes (Na/K) ,serum lactate, time to extubation, Ramsay sedation score  (RSS) ( till 4 hours post-extubation) were compared over a span of 72 hours.

RESULTS: The observations and results of our study revealed that dexmedetomidine imparted cardiac and renoprotective properties as evidenced by significantly lower levels of CPK-MB, LDH, Serum lactate, Blood urea, serum creatinine, serum sodium in Group 1 as compared to Group 2 at all the times on both post-op days (p<0.05). Time to extubation and RSS were also significantly less in Group 1.

CONCLUSION: Dexmedetomidine offers cardiac and renoprotective, analgesic sparing, and anxiolytic effects, hence should be used in cardiac surgeries.

Author Biographies

  • Dr. Mansha Madan

    Senior Resident, Department of Anaesthesia and Intensive care, VMMC and Safdarjung Hospital, New Delhi -110029

  • Dr. Meenakshi Kumar

    Professor, Department of Anaesthesia and Intensive care, VMMC and Safdarjung Hospital, New Delhi -110029

  • Dr. Sushil Guria

    Associate Professor, Department of Anaesthesia and Intensive care, VMMC and Safdarjung Hospital, New Delhi -110029

  • Dr. Aadhar Khutell

    Senior Resident, Department of Anaesthesia and Intensive care, VMMC and Safdarjung Hospital, New Delhi -110029

  • Dr. Simarjot Singh Sodhi

    MS Orthopaedics, DNB Orthopaedics, Central Institute Of Orthopaedics, VMMC and Safdarjung Hospital, New Delhi-110029

References

L.H. Edmunds, “Cardiopulmonary bypass after 50 years”. N Engl J Med. 2004;351(16):1603-6.

2. Daly RC, Dearani JA, McGregor C, Mullany C, Orszulak TA, Puga FJ, et al. Fifty years of open heart surgery at the Mayo clinic. Mayo clin Proc. 2005:80(5):630-40.

3. Henke K, Eigsti J. Bypass injury: implications of cardiopulmonary bypass. Dimens Crit Care Nurs.2003;22(2);64-70.

4. Kemp KM, Henderlight L, Neville M. Precedex: Is it the future of cooperative sedation? Nursing.2008:38:7-8.

5. Ammar AS, Mahumoud KM, Kasmy ZA, Helwa MA. Cardiac and renal protective effects of dexmedetomidine in cardiac surgeries: A randomised control trial. Saudi J Anaesth.2016;10:395-401.

6. Zhang Y, Yi D, Xiao G, Wang W, Lin W, Zeng H, et al. Myocardial protection effects of dexmedetomidine priming on cardiopulmonary bypass surgery for children with congenital heart disease. Int J Clin Exp Med.2018;11(2):975-81.

7. Chi X, Liao M, Chen X, Zhao Y, Yang L, Luo A, et al. Dexmedetomidine attenuates myocardial injury in off-pump coronary artery bypass graft surgery. J Cardiothorac Vasc Anaesth. 2016;30:44-50.

8. Munoz R, Lausssen PC, Palacio G, Zeinko L, Piercey G, Wessel DL. Changes in whole blood lactate levels during cardiopulmonary bypass for surgery for congenital cardiac disease: an early indicator of morbidity and mortality. J Thorac Cardiovasc Surg 2000;119(1):155-62.

9. Biccard BM, Goga S, de Beurs J. Dexmedetomidine and cardiac protection for noncardiac surgery: A meta-analysis of randomised controlled trials. Anaesthesia. 2008;63(1):4-14.

10. Abd Aziz N, Chuee MC, Yong CY, Hassan Y, Awaisu A, Hassan J, et al. Efficacy and safety of dexmedetomidine versus morphine in post-operative cardiac surgery patients. Int J Clin Pharm. 2011;33:150-4.

Downloads

Published

2023-10-21

How to Cite

Dr. Mansha Madan, Dr. Meenakshi Kumar, Dr. Sushil Guria, Dr. Aadhar Khutell, & Dr. Simarjot Singh Sodhi. (2023). PERIOPERATIVE DEXMEDETOMIDINE INFUSION FOR CARDIAC AND RENAL PROTECTION IN CARDIAC SURGERIES. Journal of Population Therapeutics and Clinical Pharmacology, 30(17), 2513-2520. https://doi.org/10.53555/5253z295
More Citation Formats

Issue

Section

Articles

How to Cite

Dr. Mansha Madan, Dr. Meenakshi Kumar, Dr. Sushil Guria, Dr. Aadhar Khutell, & Dr. Simarjot Singh Sodhi. (2023). PERIOPERATIVE DEXMEDETOMIDINE INFUSION FOR CARDIAC AND RENAL PROTECTION IN CARDIAC SURGERIES. Journal of Population Therapeutics and Clinical Pharmacology, 30(17), 2513-2520. https://doi.org/10.53555/5253z295

Most read articles by the same author(s)